Engrave Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Engrave Wealth Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,076	Closed	-$222K	–	71
2022 Q4	$222K	Buy	3,076 +227	+8%	+$17.1K	0.08%	65
2022 Q3	$203K	Hold	2,849	–	–	0.09%	57
2022 Q2	$219K	Buy	2,849 +7	+0.2%	+$533	0.1%	53
2022 Q1	$208K	Buy	+2,842	New	+$191K	0.08%	53
2021 Q3	–	Sell	-4,275	Closed	-$286K	–	71
2021 Q2	$286K	Buy	4,275 +139	+3%	+$9.06K	0.09%	63
2021 Q1	$261K	Buy	4,136 +242	+6%	+$15.1K	0.11%	58
2020 Q4	$252K	Buy	+3,894	New	+$239K	0.21%	49
2020 Q3	–	Sell	-3,373	Closed	-$198K	–	98
2020 Q2	$198K	Hold	3,373	–	–	0.18%	50
2020 Q1	$188K	Hold	3,373	–	–	0.22%	40
2019 Q4	$216K	Buy	+3,373	New	+$193K	0.21%	42

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Engrave Wealth Partners's BMY Position: Q1 2023 in Review

Engrave Wealth Partners sold out of Bristol-Myers Squibb (BMY) in Q1 2023, closing a stake of 3,076 shares — an estimated $222K sold.

Engrave Wealth Partners first reported a position in BMY in Q4 2019 and held it in 10 quarters. The position peaked at $286K in Q2 2021. 2,540 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

Engrave Wealth Partners reported no remaining Bristol-Myers Squibb position as of Q1 2023 after selling out during the quarter.
Engrave Wealth Partners sold 3,076 Bristol-Myers Squibb shares in Q1 2023, an estimated $222K.
Engrave Wealth Partners first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 10 quarters.
Engrave Wealth Partners's Bristol-Myers Squibb position peaked at $286K in Q2 2021.
2,540 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on Engrave Wealth Partners's 13F filing for Q1 2023, filed 26 Apr 2023.